GLP-1s are mainly used for managing diabetes and assisting with weight loss
Norwood-Hamilton Scale The standard classification system for male pattern baldness, ranging from Type I (no significant loss) to Type VII (extensive loss)
Zhijun Xie, Zhejiang Chinese Medical University, China Updates Copyright 2018 Li, Deng, Xie, Liu, Friedmann Angeli and Lai
DOI: 10.1007/s00018-024-05558-9 [Google Scholar] Fathy MA, Alsemeh AE, Habib MA, Abdel-Nour HM, Hendawy DM, Eltaweel AM, et al
Research on GLP-1 receptor agonists and new GLP-1/GIP dual receptor agonists not only reveals their neuroprotective potential but also provides new hope for PD treatment
Pooling across the field, a 2025 meta-analysis of seven randomized controlled trials, covering 456 participants, reported a standardized mean difference of -0.72 for wrinkle reduction, though the analysis noted high heterogeneity between studies and that roughly 40% of trials had industry funding both factors that warrant caution in interpreting the pooled effect size